Pear Therapeutics’ Cuts Are Not Enough; ‘Strategic Alternatives’ Among Next Steps
Pear Therapeutics isn’t meeting the commercialization goals for its prescription digital therapeutics, so it’s now seeking strategic alternatives for the business. Prospective buyers can pick up Pear’s FDA-cleared products for substance use disorder, opioid use disorder, and insomnia. The post Pear Therapeutics’ Cuts Are Not Enough; ‘Strategic Alternatives’ Among Next Steps appeared first on MedCity News.
Pear Therapeutics isn’t meeting the commercialization goals for its prescription digital therapeutics, so it’s now seeking strategic alternatives for the business. Prospective buyers can pick up Pear’s FDA-cleared products for substance use disorder, opioid use disorder, and insomnia.
The post Pear Therapeutics’ Cuts Are Not Enough; ‘Strategic Alternatives’ Among Next Steps appeared first on MedCity News.
